Nvidia Has Stakes in Arm, SoundHound, Biotech Firm Recursion
This article is for subscribers only.
Nvidia Corp., the chipmaker at the heart of an artificial intelligence spending boom, disclosed investments in Arm Holdings Plc, SoundHound AI Inc. and the biotech company Recursion Pharmaceuticals Inc.
Nvidia included the information in a 13F form filed with the US Securities and Exchange Commission on Wednesday, giving a glimpse at the closely watched company’s investment strategy. It has a history with Arm, which Nvidia attempted to acquire for $40 billion in 2020. That deal ultimately crumbled under regulatory pressure, and Nvidia walked away in February 2022. Arm was up 2.9% on Thursday as trading got underway in New York.